panretin- alitretinoin gel
eisai inc. - alitretinoin (unii: 1ua8e65kdz) (alitretinoin - unii:1ua8e65kdz) - alitretinoin 60 mg in 60 g - panretin® gel is indicated for topical treatment of cutaneous lesions in patients with aids-related kaposi’s sarcoma. panretin® gel is not indicated when systemic anti-ks therapy is required (e.g., more than 10 new ks lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary ks, or symptomatic visceral involvement). there is no experience to date using panretin® gel with systemic anti-ks treatment. panretin® gel is contraindicated in patients with a known hypersensitivity to retinoids or to any of the ingredients of the product.
acitretin 5mg/5ml oral suspension
drug tariff special order - acitretin - oral suspension - 1mg/1ml
acitretin 5mg/5ml oral solution
special order - acitretin - oral solution - 1mg/1ml
acitretin 10mg/5ml oral suspension
special order - acitretin - oral suspension - 2mg/1ml
acitretin 10mg/5ml oral solution
special order - acitretin - oral solution - 2mg/1ml
acitretin 10mg capsules
medihealth (northern) ltd - acitretin - oral capsule - 10mg
acitretin 25mg capsules
medihealth (northern) ltd - acitretin - oral capsule - 25mg
alitretinoin 10mg capsules
a a h pharmaceuticals ltd - alitretinoin - oral capsule - 10mg
alitretinoin 30mg capsules
a a h pharmaceuticals ltd - alitretinoin - oral capsule - 30mg
alitretinoin 10mg capsules
alliance healthcare (distribution) ltd - alitretinoin - oral capsule - 10mg